SPP1 and graft versus host disease: The osteopontin levels during conditioning therapy and allogeneic stem cell transplantation in humans and the possible importance for development of GVHD should be studied in further detail in order to evaluate osteopontin as a possible therapeutic target in graft versus host disease.